Challenges and Opportunities in the Use of Biomarkers in Early Phase Trials

Hosted By: Pharma IQ
10/06/2010
Rate this Podcast: 
Be the first!
To continue viewing this content please fill out the form below and become an Pharma IQ member.
Or if you're already a Pharma IQ member, sign in below to download.
Join

By entering in your information and submitting the form, you give the sponsor permission to contact you regarding their product and you agree to our User Agreement, Privacy Policy, and Cookie Policy.

About this Podcast...

In this interview Martin Jenkins, Senior Statistician at AstraZeneca, speaks to Andrea Charles from Pharma IQ, about exploring the potential uses of biomarkers to enhance early clinical development, at which points they should be utilised and how. Jenkins draws attention to the practical challenges that arise in the use of biomarkers and shares his insights on how the role of the statistician has evolved in clinical design and analysis.

EVENTS OF INTEREST

Crowne Plaza Zurich, Zurich, Switzerland
June 17 - 19, 2018